![](https://endpts.com/wp-content/uploads/2024/05/Eden-Wells-Novartis-FT-Summit-feature.jpg)
Eden Wells, Novartis chief insights and decision science officer, at the Financial Times' US Pharma and Biotech Summit, held in partnership with Endpoints News (Sarah Merians Photography for Endpoints News)
Pharma is rethinking how it interacts with patients after Eli Lilly ripped up the playbook
(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.)
More pharma companies …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.